ArticleFrontiers in pharmacology2025

ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K/AKT and ERK1/2 pathways.

Mengyuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.